Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13GFiled 6 days ago

AbCellera Biologics Inc.: Hansen Carl L. G. amends Schedule 13G stake filing

Open the sourceReported by SEC EDGAR SCHEDULE 13G, sec.gov, 13 November 2026, by SEC EDGAR SCHEDULE 13G

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

Carl L. G. Hansen amended his Schedule 13G beneficial ownership filing for AbCellera Biologics Inc., disclosing the change to the SEC under accession number 0001193125-26-460670. The filing updates Hansen's reported stake in the antibody discovery company, though the amendment's specific share count and percentage were not detailed in the headline disclosure. Schedule 13G amendments are typically filed by passive investors and must be updated when holdings cross certain thresholds or materially change. Investors will watch for the full filing text to confirm whether Hansen's position increased or decreased and by how much.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.

Named in this story

Carl L. G. Hansen, AbCellera Biologics Inc.